A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/165 (2006.01) A61K 31/167 (2006.01) A61K 31/56 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2644733
An improved method of increasing tear production is by intranasally administering a therapeutically effective amount of a capsaicinoid compound to patients with deficient tear production. Optional incorporation into the intranasal formulation of a topical corticosteroid or topical anesthetic compound is used to reduce transient nasal stinging and burning which may sometimes accompany intranasal administration of capsaicinoids.
L'invention porte sur un procédé amélioré pour augmenter la production de larmes par administration intranasale d'une quantité thérapeutiquement efficace d'un composé capsaicinoïde à des patients ayant une production de larmes déficiente. Une incorporation facultative dans la formulation intranasale d'un corticostéroïde topique ou d'un composé anesthésique topique est utilisée pour réduire la sensation urticante et brûlante nasale transitoire qui peut parfois accompagner l'administration intranasale des capsaicinoïdes.
Torys Llp
Winston Laboratories Inc.
LandOfFree
Method for alleviating keratoconjunctivitis sicca does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for alleviating keratoconjunctivitis sicca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for alleviating keratoconjunctivitis sicca will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1411932